インスリンの消化管吸収に対するキモトリプシン阻害剤FK-448の増強作用

スポンサーリンク

概要

• 論文の詳細を見る

• The role of the chymotrypsin inhibitor, 4-(4-isopropylpiperazinocarbonyl)phenyl 1,2,3,4-tetrahydro-1-naphthoate methanesulfonate (FK-448) in the promoting effect on the intestinal absorption of insulin was studied. After administration of insulin(63U/kg) into the intestinal loop of the rat, the immunoreactive insulin(IRI) level in the portal plasma reached 49±2μU/ml, but the blood glucose level remained unchanged. When insulin was administered at the same dose with FK-448(20mg/kg), the IRI level increased to 331±91 μU/ml and the blood glucose level was decreased by 40% as compared with that before administration. The percentage of insulin absorption was estimated to be about 0.7(7 times over control) by using the area under the plasma IRI concentration-time curve(AUC) after intramesenteric venous administration of known amounts of insulin. When insulin alone was administered into the intestinal loop after washing for 30 min with Krebs-Henseleit solution, the AUC was not significantly different from that without washing. This means that insulin administered into the intestine is degraded by digestive enzymes adsorbed onto the mucosal glycocalyx or those in the mucous membrane. To clarify the role of FK-448 in its promoting effect on the intestinal absorption of insulin, the influence on the permeability of intestinal mucosa was examined by measuring the extent of exsorption of sulfanilic acid into the small intestine. FK-448 exhibits no enhanced permeability of the intestinal mucosa which accounts for the observed promoting effect on the intestinal absorption of insulin. Therefore, the promoting effect of FK-448 on the intestinal absorption of insulin was considered to be based on the inhibition of proteolytic enzyme(s), but the results above mentioned could not reveal where insulin administered into the intestinal tract was mainly degraded.

• 公益社団法人日本薬学会の論文
• 1988-02-25

著者

• 横尾 信夫

  興和株式会社東京研究所

• 鈴木 徳治

  Faculty of Pharmaceutical Sciences, Chiba University

• 藤井 節郎

  財団法人・大阪基礎医学研究奨励会

• 鈴木 徳治

  千葉大 薬

• 鈴木 徳治

  千葉大学薬学部

• 横尾 信夫

  興和株式会社・東京研究所

関連論文

• 水溶性キモトリプシン阻害剤の合成研究(第2報)
• 水溶性キモトリプシン阻害剤の合成研究
• A NEW STATISTICAL PROCEDURE OF INTERVAL HYPOTHESIS TESTING FOR BIOEQUIVALENCE STUDIES
• 2-(3-Pyridyl)thiazolidine-4-carboxamide Derivatives. II. Structure-Activity Relationships and Active Configuration of 2-(3-Pyridyl)thiazolidine-4-carboxamides as Platelet-Activating Factor Receptor Antagonists
• Synthesis and Biological Activity of the Metabolites of N-[2-(1-Azabicyclo[3.3.0]octan-5-yl)ethyl]-2-nitroaniline Fumarate (SK-946)
• Synthesis of (1-Azabicyclo[3.3.0]octanyl)methyl-Substituted Aromatic Heterocycles and Their Muscarinic Activity
• Determination of Phenylbutazone and Its Metabolites in Plasma by Gas-Liquid Chromatographic Procedure
• An Improved Synthesis of Butyl 4-[(4-Amino-5-chloro-2-methoxybenzoyl)amino]-1-piperidineacetate (AU-224)
• Structure-Activity Relationship(SAR)Studies on Oxazolidinone Antibacterial Agents.1. Conversion of 5-Substituent on Oxazolidinone
• 薬物のBioavailability (最新薬物療法manual--投薬の基本と治療プログラム) -- (薬物投与の基礎理論--PharmacokineticsとPharmacodynamics)
• 製剤の進歩による新しい薬剤 (新しい薬--その開発と臨床応用)
• Characterization of the Neurochemical Effects of N-[2-(1-azabicyclo[3,3,0]octan-5-yl)ethyl]2-nitroaniline fumarate (SK-946) as a Cognition Activator
• Simple Method for Repetitive Blood Sampling in a Self-Controlled Design in the Rat
• Drug Absorption and Metabolism Studies by Use of Portal Vein Infusion in the Rat. II. Influence of Dose and Infusion Rate on the Bioavailability of Propranolol
• Pharmacokinetic Analysis of Blood Level Data interpreted by a Two-Compartment Model
• Drug Absorption and Metabolism Studies by Use of Portal Vein Infusion in the Rat. I. Pyloric Vein Cannulation and Its Application to Study of First-Pass Effect on Bioavailability of Propranolol
• インスリンの消化管吸収に対するキモトリプシン阻害剤FK-448の増強作用
• New Approach to the Hepatic First-Pass Effect by Whole-Body Autoradiography
• Immunoliposome-Mediated Gene Transfer into Cultured Myotubes
• Examination of Local Anti-inflammatory Activities of New Steroids, Hemisuccinyl Methyl Glycolates
• アドレナリンβ-遮断薬o-[3-(tert-Butylamino)-2-hydroxypropoxy]benzonitrile(Bunitrolol)の代謝に及ぼす投与経路の影響
• マイクロコンピュータを用いたシンプレックス法による薬物速度論的パラメータの推定
• Modification by Fluoride, Bromide, Iodide, Thiocyanate and Nitrite Anions of Reaction of a Myeloperoxidase-H_2O_2-Cl^- System with Nucleosides
• Effects of Fluvastatin and Its Major Metabolites on Low-Density Lipoprotein Oxidation and Cholesterol Esterification in Macrophages
• Fluvastatin, an HMG-CoA Reductase Inhibitor, Protects LDL from Oxidative Modification in Hypercholesterolemic Rabbits
• In Vitro Inhibitory Effects of the Optical Isomers and Metabolites of Fluvastatin on Copper Ion-Induced LDL Oxidation
• An in Vitro Study of the Hydroxyl Radical Scavengin Property of Fluvastatin, and HMG-CoA Reductase Inhibitor
• 生物学的同等性の判定における仮説検定法, 区間推定法, 及びBayes流の解析法の比較
• 初回通過効果 : 生物学的利用性に影響する要因
• Inhibitory Effects of Fidarestat on Aldose Reductase and Aldehyde Reductase Activity Evaluated by a New Method Using HPLC with Post-column Spectrophotometric Detection
• 2-(3-Pyridyl)thiazolidine-4-carboxamide Derivatives. III. Synthesis of Metabolites and Metabolism of 2-(3-Pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as Platelet-Activating Factor (PAF) Receptor Antagonists
• Synthesis of the Selective 5-Hydroxytryptamine 4 (5-HT_4) Receptor Agonist (+)-(S)-2-Chloro-5-methoxy-4-[5-(2-piperidylmethyl)-1,2,4-oxadiazol-3-yl]aniline
• Intramolecular Oxymercuration with Mercuric Triflate
• Mercuric Triflate-TMU Catalyzed Hydration of Terminal Alkyne to give Methyl Ketone under Mild Conditions
• Effects of N-[2-(1-Azabicyclo[3,3,0]octan-5-yl)ethyl]2-nitroaniline Fumarate (SK-946), a Novel Cognition Activator, on Learning and Memory in Rodent Models
• Novel 5-Hydroxytryptamine 4 (5-HT_4) Receptor Agonists. Synthesis and Gastroprokinetic Activity of 4-Amino-N-[2-(1-aminocycloalkan-1-yl)ethyl]-5-chloro-2-methoxybenzamides
• Effect of repeated administration of propranolol on liver metabolism and its factors.
• Oral Administration of Insulin with Chymotrypsin Inhibitors
• The Effect of Chymotrypsin Inhibitors on the Intestinal Absorption of Insulin
• Effect of repeated administration of propranolol on non-linear first pass metabolism.
• Strain specificity of metabolism of propranolol and lidocaine in rats.
• Problems with pharmacotherapy in elderly patients. 1. Specificity of variation in metabolic activities accompanying senile change.
• タイトル無し

もっと見る 閉じる

スポンサーリンク